Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE3.3500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.1400/ 1
- Ask / Lots3.4600/ 15
- Open / Previous Close0.0000 / 3.3500
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 31590 | 3.05 |
| 09:34 ET | 25140 | 3 |
| 09:36 ET | 14650 | 3.04 |
| 09:39 ET | 22727 | 3.11 |
| 09:41 ET | 16372 | 3.145 |
| 09:43 ET | 2992 | 3.12 |
| 09:45 ET | 29174 | 3.145 |
| 09:48 ET | 6318 | 3.12 |
| 09:50 ET | 27708 | 3.14 |
| 09:52 ET | 2850 | 3.105 |
| 09:54 ET | 2000 | 3.105 |
| 09:56 ET | 700 | 3.105 |
| 09:57 ET | 2900 | 3.1 |
| 09:59 ET | 400 | 3.1 |
| 10:01 ET | 5894 | 3.105 |
| 10:03 ET | 600 | 3.105 |
| 10:06 ET | 1200 | 3.1 |
| 10:08 ET | 400 | 3.1 |
| 10:10 ET | 28352 | 3.13 |
| 10:12 ET | 15376 | 3.12 |
| 10:14 ET | 3200 | 3.115 |
| 10:15 ET | 21694 | 3.135 |
| 10:17 ET | 35174 | 3.195 |
| 10:19 ET | 16861 | 3.2 |
| 10:21 ET | 20540 | 3.205 |
| 10:24 ET | 2617 | 3.235 |
| 10:26 ET | 2030 | 3.19 |
| 10:28 ET | 819 | 3.19 |
| 10:30 ET | 12553 | 3.17 |
| 10:32 ET | 10009 | 3.19 |
| 10:33 ET | 12499 | 3.2 |
| 10:35 ET | 69234 | 3.26 |
| 10:37 ET | 21206 | 3.265 |
| 10:39 ET | 134383 | 3.2697 |
| 10:42 ET | 49772 | 3.3277 |
| 10:44 ET | 21556 | 3.3795 |
| 10:46 ET | 29477 | 3.38 |
| 10:48 ET | 88964 | 3.415 |
| 10:50 ET | 56068 | 3.435 |
| 10:51 ET | 18600 | 3.4342 |
| 10:53 ET | 29267 | 3.45 |
| 10:55 ET | 27131 | 3.441 |
| 10:57 ET | 35337 | 3.485 |
| 11:00 ET | 61404 | 3.5199 |
| 11:02 ET | 31472 | 3.46 |
| 11:04 ET | 87049 | 3.455 |
| 11:06 ET | 3986 | 3.48 |
| 11:08 ET | 45530 | 3.47 |
| 11:09 ET | 45902 | 3.4701 |
| 11:11 ET | 26969 | 3.455 |
| 11:13 ET | 28959 | 3.45 |
| 11:15 ET | 9476 | 3.445 |
| 11:18 ET | 6412 | 3.465 |
| 11:20 ET | 41520 | 3.48 |
| 11:22 ET | 5525 | 3.47 |
| 11:24 ET | 3244 | 3.49 |
| 11:26 ET | 6125 | 3.49 |
| 11:27 ET | 1820 | 3.48 |
| 11:29 ET | 19989 | 3.4699 |
| 11:31 ET | 31763 | 3.385 |
| 11:33 ET | 7274 | 3.38 |
| 11:36 ET | 8376 | 3.375 |
| 11:38 ET | 14083 | 3.375 |
| 11:40 ET | 556 | 3.372 |
| 11:42 ET | 37083 | 3.33 |
| 11:44 ET | 25574 | 3.32 |
| 11:45 ET | 6528 | 3.34 |
| 11:47 ET | 3881 | 3.335 |
| 11:49 ET | 8513 | 3.325 |
| 11:51 ET | 7396 | 3.34 |
| 11:54 ET | 64247 | 3.325 |
| 11:56 ET | 735 | 3.32 |
| 11:58 ET | 101891 | 3.32 |
| 12:00 ET | 5761 | 3.29 |
| 12:02 ET | 14502 | 3.31 |
| 12:03 ET | 10659 | 3.3 |
| 12:05 ET | 2278 | 3.31 |
| 12:07 ET | 26264 | 3.27 |
| 12:09 ET | 11702 | 3.265 |
| 12:12 ET | 18614 | 3.26 |
| 12:14 ET | 2093 | 3.26 |
| 12:16 ET | 19082 | 3.245 |
| 12:18 ET | 126 | 3.245 |
| 12:20 ET | 660 | 3.245 |
| 12:21 ET | 1200 | 3.24 |
| 12:23 ET | 3220 | 3.22 |
| 12:25 ET | 43534 | 3.1984 |
| 12:27 ET | 7588 | 3.18 |
| 12:30 ET | 11952 | 3.1695 |
| 12:32 ET | 10199 | 3.2 |
| 12:34 ET | 1671 | 3.175 |
| 12:36 ET | 200 | 3.175 |
| 12:38 ET | 7297 | 3.195 |
| 12:39 ET | 1700 | 3.19 |
| 12:41 ET | 4200 | 3.188 |
| 12:43 ET | 1014 | 3.19 |
| 12:45 ET | 479 | 3.185 |
| 12:48 ET | 1032 | 3.185 |
| 12:50 ET | 452 | 3.185 |
| 12:52 ET | 100 | 3.18 |
| 12:54 ET | 931 | 3.19 |
| 12:56 ET | 400 | 3.185 |
| 12:57 ET | 556 | 3.19 |
| 12:59 ET | 4500 | 3.205 |
| 01:01 ET | 12832 | 3.215 |
| 01:03 ET | 10746 | 3.195 |
| 01:06 ET | 4162 | 3.1806 |
| 01:08 ET | 3302 | 3.19 |
| 01:10 ET | 1700 | 3.1865 |
| 01:12 ET | 500 | 3.185 |
| 01:14 ET | 2793 | 3.2 |
| 01:15 ET | 3539 | 3.2 |
| 01:17 ET | 209 | 3.2 |
| 01:19 ET | 1019 | 3.19 |
| 01:21 ET | 799 | 3.18 |
| 01:24 ET | 7243 | 3.19 |
| 01:26 ET | 2600 | 3.205 |
| 01:28 ET | 4525 | 3.195 |
| 01:30 ET | 680 | 3.2 |
| 01:32 ET | 2470 | 3.198 |
| 01:33 ET | 500 | 3.195 |
| 01:35 ET | 1197 | 3.2 |
| 01:37 ET | 3100 | 3.198 |
| 01:39 ET | 1675 | 3.2 |
| 01:42 ET | 8390 | 3.168 |
| 01:44 ET | 16424 | 3.16 |
| 01:46 ET | 5228 | 3.15 |
| 01:48 ET | 4593 | 3.145 |
| 01:50 ET | 12845 | 3.175 |
| 01:51 ET | 400 | 3.175 |
| 01:53 ET | 815 | 3.185 |
| 01:55 ET | 300 | 3.188 |
| 01:57 ET | 6792 | 3.19 |
| 02:00 ET | 7894 | 3.19 |
| 02:02 ET | 4000 | 3.1995 |
| 02:04 ET | 11724 | 3.18 |
| 02:06 ET | 4154 | 3.178 |
| 02:08 ET | 4676 | 3.19 |
| 02:09 ET | 4674 | 3.205 |
| 02:11 ET | 3102 | 3.21 |
| 02:13 ET | 300 | 3.22 |
| 02:15 ET | 11412 | 3.2248 |
| 02:18 ET | 7399 | 3.22 |
| 02:20 ET | 13204 | 3.22 |
| 02:22 ET | 15484 | 3.221 |
| 02:24 ET | 3664 | 3.23 |
| 02:26 ET | 3801 | 3.21 |
| 02:27 ET | 3325 | 3.21 |
| 02:29 ET | 3148 | 3.23 |
| 02:31 ET | 11689 | 3.23 |
| 02:33 ET | 1700 | 3.21 |
| 02:36 ET | 700 | 3.2224 |
| 02:38 ET | 1170 | 3.2299 |
| 02:40 ET | 3200 | 3.22 |
| 02:42 ET | 3256 | 3.21 |
| 02:44 ET | 300 | 3.215 |
| 02:45 ET | 300 | 3.22 |
| 02:47 ET | 1650 | 3.215 |
| 02:49 ET | 1869 | 3.22 |
| 02:51 ET | 10924 | 3.2 |
| 02:54 ET | 1155 | 3.21 |
| 02:56 ET | 400 | 3.21 |
| 02:58 ET | 7529 | 3.22 |
| 03:00 ET | 600 | 3.22 |
| 03:02 ET | 452 | 3.2175 |
| 03:03 ET | 6852 | 3.2175 |
| 03:05 ET | 4200 | 3.2102 |
| 03:07 ET | 200 | 3.215 |
| 03:09 ET | 9000 | 3.228 |
| 03:12 ET | 1437 | 3.215 |
| 03:14 ET | 100 | 3.215 |
| 03:16 ET | 14781 | 3.215 |
| 03:18 ET | 650 | 3.215 |
| 03:20 ET | 5379 | 3.24 |
| 03:21 ET | 9508 | 3.2299 |
| 03:23 ET | 3500 | 3.23 |
| 03:25 ET | 3303 | 3.24 |
| 03:27 ET | 7930 | 3.225 |
| 03:30 ET | 5000 | 3.23 |
| 03:32 ET | 19981 | 3.255 |
| 03:34 ET | 21162 | 3.26 |
| 03:36 ET | 20697 | 3.26 |
| 03:38 ET | 12043 | 3.26 |
| 03:39 ET | 12640 | 3.275 |
| 03:41 ET | 17717 | 3.27 |
| 03:43 ET | 13978 | 3.28 |
| 03:45 ET | 14500 | 3.295 |
| 03:48 ET | 10197 | 3.295 |
| 03:50 ET | 10192 | 3.295 |
| 03:52 ET | 34468 | 3.305 |
| 03:54 ET | 20461 | 3.3 |
| 03:56 ET | 48989 | 3.29 |
| 03:57 ET | 39830 | 3.29 |
| 03:59 ET | 69264 | 3.35 |
May 16, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 11:16AM ET on Thursday May 16, 2024 by Dow Jones
11:16AM ET on Thursday May 16, 2024 by Dow JonesDJ Mereo BioPharma Group Price Target Maintained With a $6.00/Share by Needham, from 7:33AM ET on Thursday May 16, 2024 by Dow Jones
7:33AM ET on Thursday May 16, 2024 by Dow Jones
May 15, 2024
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update, from 4:01PM ET on Wednesday May 15, 2024 by Dow Jones
4:01PM ET on Wednesday May 15, 2024 by Dow JonesPress Release: Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update, from 4:01PM ET on Wednesday May 15, 2024 by Dow Jones
4:01PM ET on Wednesday May 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 469.9M | -12.6x | --- |
Erasca Inc | 599.7M | -3.0x | --- |
Mind Medicine (MindMed) Inc | 600.5M | -2.8x | --- |
Oric Pharmaceuticals Inc | 594.0M | -4.9x | --- |
Mineralys Therapeutics Inc | 603.7M | -5.6x | --- |
Oculis Holding AG | 552.7M | -6.6x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $469.9M |
|---|---|
Revenue (TTM) | $9.1M |
Shares Outstanding | 140.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.71 |
EPS | $-0.27 |
Book Value | $0.63 |
P/E Ratio | -12.6x |
Price/Sales (TTM) | 51.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -444.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
